Psychiatr. praxi 2019; 20(3): 114-119 | DOI: 10.36290/psy.2019.026

Excessive sleepiness in the context of neurological and mental disorders

Mgr. et Bc. Roman Adamczyk, Ph.D.
Fakulta veřejných politik v Opavě

Excessive sleepiness (hypersomnolence) is a relatively common occurrence following sleep deprivation and, similarly, a prevalent symptom accompanying a number of neurological, psychiatric and other medical disorders, infections and traumas. The presence of excessive sleepiness in neurodegenerative diseases, vascular cerebral accidents, as well as CNS injuries, tumours and infections, and the existence of central disorders of hypersomnolence represent a significant clinical challenge in neurology. Increased prevalence of hypersomnolence has also been observed in mental disorders. Considering the impact of hypersomnolence on social functioning and the quality of life, excessive sleepiness is currently subject to intense clinical research.

Keywords: excessive sleepiness, hypersomnolence, neurological disorders, mental disorders

Published: October 11, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamczyk R. Excessive sleepiness in the context of neurological and mental disorders. Psychiatr. praxi. 2019;20(3):114-119. doi: 10.36290/psy.2019.026.
Download citation

References

  1. AASM. American Academy of Sleep Medicine. ICSD-3. The International Classification of Sleep Disorders - Third Edition. 3rd ed. Darien: American Academy of Sleep Medicine 2014.
  2. Nevšímalová S. Disorders associated with increased sleepiness. In: Nevšímalová S, Bruni O, eds. Sleep Disorders in Children. 1st ed. Cham: Springer 2017: 281-304. Go to original source...
  3. APA. DSM-V. Diagnostický a statistický manuál duševních poruch DSM-5. 5. vydání. Praha: Hogrefe - Testcentrum 2015.
  4. ÚZIS. MKN 10. Mezinárodní statistická klasifikace nemocí a přidružených zdravotních problémů. Desátá revize. Obsahová aktualizace k 1. 1. 2018. Tabelární část. (online). Dostupné z URL: https://www.uzis.cz/system/files/mkn-tabelarni-cast_1-1-2018.pdf.
  5. WHO. MKN-11 beta. International Classification of Diseases for Mortality and Morbidity Statistics. Eleventh Revision. Updated April 2019. (online). Dostupné z URL: https://icd.who.int/browse11/l-m/en.
  6. Overeem S, Reading P. Sleep Disorders in Neurology. A Practical Approach. 2nd ed. Oxford: Wiley Blackwell, 2018. Go to original source...
  7. Neu D, Linkowski P, Le Bon O. Clinical complaints of daytime sleepiness and fatigue: How to distinguish and treat them, especially when they become, excessive' or, chronic'? Acta Neurol Belg 2010 Mar; 110 (1): 15-25. Go to PubMed...
  8. Guilleminault C, Brooks SN. Excessive daytime sleepiness: A challenge for the practising neurologist. Brain 2001; 124 (8): 1482-1491. doi: 10.1093/brain/124. 8. 1482. Go to original source... Go to PubMed...
  9. Inutsuka A, Yamanaka A. The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. Front Endocrinol (Lausanne) 2013; 4: 18. doi: 10.3389/fendo.2013.00018. Go to original source...
  10. Ohayon MM. From wakefulness to excessive sleepiness: What we know and still need to know. Sleep Med Rev 2008 Apr; 12 (2): 129-141. doi: 10.1016/j.smrv.2008. 01. 001. Go to original source... Go to PubMed...
  11. Dauvilliers Y. Differential diagnosis in hypersomnia. Curr Neurol Neurosci Rep 2006 Mar; 6 (2): 156-162. Go to original source... Go to PubMed...
  12. Buysse DJ, Oldham JM. Sleep Disorders and Psychiatry. 1st ed. Arlington: American Psychiatric Publishing 2005.
  13. Sowa NA. Idiopathic hypersomnia and hypersomnolence disorder: A systematic review of the literature. Psychosomatics 2016 Mar-Apr; 57 (2): 152-64. doi: 0.1016/j.psym.2015. 12. 006. Go to original source... Go to PubMed...
  14. Khan Z, Trotti LM. Central disorders of hypersomnolence. Focus on the narcolepsies and idiopathic hypersomnia. Chest 2015 Jul; 148 (1): 262-273. doi: 10.1378/chest.14-1304. Go to original source... Go to PubMed...
  15. Roehrs T, Carskadon MA, Dement W, et al. Daytime sleepiness and alertness. In: Kryger H, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. 6th ed. Amsterdam: Elsevier 2017: 42-51. Go to original source...
  16. Bassetti CL. Primary and secondary neurogenic hypersomnias. Sleep Med Clin 2012 Jun; 7 (2): 249-261. Go to original source...
  17. Maung SC, El Sara A, Chapman C, et al. Sleep disorders and chronic kidney disease. World J Nephrol 2016; 5 (3): 224-232. doi: 10.5527/wjn.v5.i3.224. Go to original source...
  18. Gilden D. Neuroinfections. 1st ed. Oxford: Oxford University Press 2013. Go to original source...
  19. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14 (6): 540-545. Go to original source... Go to PubMed...
  20. Šonka K. Narkolepsie, idiopatická hypersomnie a další centrální nemoci s hypersomnolencí. Revue České lékařské akademie 2015; 11: 16-19.
  21. Smith S, Rossdale J, Serry Y, et al. Multiple dimensions of excessive daytime sleepiness. J Thorac Dis 2018; 10(Suppl 1): S170-S176. doi:10.21037/jtd.2017. 11. 32. Go to original source... Go to PubMed...
  22. Chokroverty S, Provini F. Kleine-Levin. In: Chokroverty S, ed. Sleep Disorders Medicine. Basic Science, Technical Considerations, and Clinical Aspects. 4th ed. New York: Springer-Verlag 2017: 787-890. Go to original source...
  23. Saini P, Rye DB. Hypersomnia: Evaluation, treatment, and social and economic aspects. In: Krieger A., ed. Social and Economic Dimensions of Sleep Disorders, An Issue of Sleep Medicine Clinics, Volume 12-1. 1st ed. New York: Elsevier 2017: 47-60. Go to original source...
  24. Trotti LM, Saini P, Koola C, et al. Flumazenil for the treatment of refractory hypersomnolence: Clinical experience with 153 patients. J Clin Sleep Med 2016 Oct; 12 (10): 1389-1394. doi: 10.5664/jcsm.6196. Go to original source...
  25. Evangelista E, Lopez R, Dauvilliers Y. Update on treatment for idiopathic hypersomnia. Expert Opin Investig Drugs 2018 Feb; 27 (2): 187-192. doi: 10.1080/13543784.2018.1417385. Go to original source... Go to PubMed...
  26. Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis 2012; 4 (6): 608-616. doi: 10.3978/j.issn.2072-1439.2012.10.07. Go to PubMed...
  27. Giorelli AS, Passos P, Carnaval T, et al. Excessive daytime sleepiness and epilepsy: A systematic review. Epilepsy Res Treat 2013; 2013: 629469. doi: 10.1155/2013/629469. Go to original source...
  28. Chahine L, Amara A, Videnovic A. A Systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005-2015. Sleep Med Rev 2017 Oct; 35: 35-50. doi: 10.1016/j.smrv.2016. 08. 001. Go to original source...
  29. Leng Y, Goldman SM, Cawthon PM, et al. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men. Int J Epidemiol 2018 Oct; 47 (5): 1679-1686. doi: 10.1093/ije/dyy098. Go to original source...
  30. Zhu K, van Hilten JJ, Marinus J. Course and risk factors for excessive daytime sleepiness in Parkinson's disease. Parkinsonism Relat Disord 2016 Mar; 24: 34-40. doi: 10.1016/j.parkreldis.2016.01.020. Go to original source... Go to PubMed...
  31. Kanbayashi T, Shimohata T, Nakashima I, et al. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis. New neurochemical and immunological implications. Arch Neurol 2009 Dec; 66 (12): 1563-1566. doi: 10.1001/archneurol.2009.264. Go to original source...
  32. Braga DM, Prado GF, Bichueti DB, et al. Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr 2016 Jun; 74 (6): 433-438. doi: 10.1590/0004-282X20160069. Go to original source...
  33. Brass SD, Li C-S, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 2014; 10 (9): 1025-1031. doi: 10.5664/jcsm.4044. Go to original source...
  34. Popp RF, Fierlbeck AK, Knüttel H, et al. Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool. Sleep Med Rev 2017 Apr; 32: 95-108. doi: 10.1016/j.smrv.2016.03.004. Go to original source...
  35. Sommerauer M, Valko PO, Werth E, et al. Excessive sleep need following traumatic brain injury: A case-control study of 36 patients. J Sleep Res 2013 Dec; 22 (6): 634-639. doi: 10.1111/jsr.12068. Go to original source... Go to PubMed...
  36. Imbach LL, Büchele F, Valko PO, et al. Sleep-wake disorders persist 18 months after traumatic brain injury but remain underrecognized. Neurology 2016 May; 86 (21): 1945-1949. doi: 10.1212/WNL.0000000000002697. Go to original source... Go to PubMed...
  37. Bassetti CL, Valko P. Poststroke hypersomnia. Sleep Med Clin 2006 Mar; 1 (1): 139-155. https://doi.org/10.1016/j.jsmc.2005.11.012. Go to original source...
  38. Lucke-Wold BP, Smith KE, Nguyen L, et al. Sleep disruption and the sequelae associated with traumatic brain injury. Neurosci Biobehav Rev 2015 Aug; 55: 68-77. doi: 10.1016/j.neubiorev.2015.04.010. Go to original source... Go to PubMed...
  39. Imbach LL, Valko PO, Li T, et al. Increased sleep need and daytime sleepiness 6 months after traumatic brain injury: a prospective controlled clinical trial. Brain 2015 Mar; 138 (Pt 3): 726-735. doi: 10.1093/brain/awu391. Go to original source... Go to PubMed...
  40. Armstrong TS, Shade MY, Breton G, et al. Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology 2017 Mar; 19 (3): 323-335. doi: 10.1093/neuonc/now119. Go to original source... Go to PubMed...
  41. Snow A, Gozal E, Malhotra A, Tiosano D, et al. Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: Clinical characteristics and potential mechanisms. Pediatrics 2002 Dec; 110 (6): e74. Go to original source... Go to PubMed...
  42. Rousselle C, des Portes V, Berlier P, et al. Pineal region tumors: Clinical symptoms and syndromes. Neurochirurgie 2015 Apr-Jun; 61 (2-3): 106-112. doi: 10.1016/j.neuchi.2013. 08. 009. Go to original source... Go to PubMed...
  43. Autret A, Lucas B, Mondon K, et al. Sleep and brain lesions: a critical review of the literature and additional new cases. Neurophysiol Clin 2001 Dec; 31 (6): 356-375. Go to original source...
  44. Giffin NJ, Lipton RB, Silberstein SD, et al. The migraine postdrome. An electronic diary study. Neurology 2016 Jul 19; 87 (3): 309-313. doi: 10.1212/WNL.0000000000002789. Go to original source... Go to PubMed...
  45. Montagnese S, Turco M, Amodio P. Hepatic encephalopathy and sleepiness: An interesting connection? J Clin Exp Hepatol 2015 Mar; 5 (Suppl 1): S49-S53. doi: 10.1016/j.jceh.2014. 06. 006. Go to original source... Go to PubMed...
  46. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Minimal hepatic encephalopathy: A vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102 (9): 1903-1909. doi: 10.1111/j.1572-0241.2007.01424.x. Go to original source... Go to PubMed...
  47. Singh SK, Růžek D. Neuroviral Infections: RNA viruses and retroviruses. 1st ed. Boca Raton: CRC Press 2013. Go to original source...
  48. Krbková L, Štroblová H., Bednářová J. Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic). Eur J Pediatr 2015; 174 (4): 449-458. doi:10.1007/s00431-014-2401-8. Go to original source... Go to PubMed...
  49. Pardasani V, Shukla G, Singh S, et al. Abnormal sleep-wake cycles in patients with tuberculous meningitis: A case-control study. J Neurol Sci 2008 Jun 15; 269 (1-2): 126-132. doi: 10.1016/j.jns.2008. 01. 003. Go to original source... Go to PubMed...
  50. Pollak C, Thorpy MJ, Yager J. The Encyclopedia of Sleep and Sleep Disorders. 3rd ed. New York: Facts on File 2010.
  51. Guilleminault C, Mondini S. Mononucleosis and chronic daytime sleepiness. A long-term follow-up study. Arch Intern Med 1986; 146 (7): 1333-1335. doi: 10.1001/archinte.1986.00360190107014. Go to original source...
  52. Macsween KF, Higgins CD, McAulay KA, et al. Infectious mononucleosis in university students in the United Kingdom: Evaluation of the clinical features and consequences of the disease. Clin Infect Dis 2010 Mar; 50 (5): 699-706. doi: 10.1086/650456. Go to original source... Go to PubMed...
  53. Soehner AM, Harvey AG. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: Results from a nationally representative sample. Sleep 2012 Oct; 35 (10): 1367-1375. doi: 10.5665/sleep.2116. Go to original source... Go to PubMed...
  54. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: A global survey with the Beck depression scale. Sleep Med 2003 Jul; 4 (4): 343-345. Go to original source... Go to PubMed...
  55. Plante DT. Hypersomnia in mood disorders: A rapidly changing landscape. Curr Sleep Med Rep 2015 Jun; 1 (2): 122-130. doi: 10.1007/s40675-015-0017-9. Go to original source... Go to PubMed...
  56. Harvey AG. Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. Am J Psychiatry 2008; 165 (7): 820-829. doi: 10.1176/appi.ajp.2008.08010098. Go to original source... Go to PubMed...
  57. Steinan MK, Scott J, Lagerberg TV, et al. Sleep problems in bipolar disorders: More than just insomnia. Acta Psychiatr Scand 2016 May; 133 (5): 368-377. doi: 10.1111/acps.12523. Go to original source... Go to PubMed...
  58. Kaplan KA, McGlinchey EL, Soehner A, et al. Hypersomnia subtypes, sleep and relapse in bipolar disorder. Psychol Med. 2015 Jun; 45 (8): 1751-1763. doi: 10.1017/S0033291714002918. Go to original source... Go to PubMed...
  59. Plante DT. Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings. Sleep Med Rev 2017 Feb; 31: 48-57. doi: 10.1016/j.smrv.2016. 01. 004. Go to original source... Go to PubMed...
  60. Staner L. Sleep and anxiety disorders. Dialogues Clin Neurosci 2003 Sep; 5 (3): 249-258. Go to original source...
  61. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatric Res 2003; 37 (1): 9-15. Go to original source... Go to PubMed...
  62. Ohayon MM, Dauvilliers Y, Reynolds CF. Operational definitions and algorithms for excessive sleepiness in the general population: Implications for DSM-5 nosology. Arch Gen Psychiatry 2012 Jan; 69 (1): 71-79. doi: 10.1001/archgenpsychiatry.2011.1240. Go to original source... Go to PubMed...
  63. Sharma P, Dikshit R, Shah N, et al. Excessive daytime sleepiness in schizophrenia: A naturalistic clinical study. J Clin Diagn Res 2016; 10 (10): VC06-VC08. doi: 10.7860/JCDR/2016/21272.8627. Go to original source... Go to PubMed...
  64. Fortuyn HD, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: A case-control study. Sleep 2008 Mar; 31 (3): 335-341. Go to original source... Go to PubMed...
  65. Dahmen N, Becht J, Engel A, et al. Prevalence of eating disorders and eating attacks in narcolepsy. Neuropsychiatr Dis Treat. 2008 Feb; 4 (1): 257-261. Go to original source...
  66. Barateau L, Jaussent I, Lopez R, et al. Smoking, alcohol, drug use, abuse and dependence in narcolepsy and idiopathic hypersomnia: A case-control study. Sleep 2016 Mar; 39 (3): 573-580. doi: 10.5665/sleep.5530. Go to original source... Go to PubMed...
  67. Peřinová P, Wierzbicka A, Feketeová E, et al. Prevalence kouření u středoevropských pacientů s narkolepsií s kataplexií, narkolepsií bez kataplexie a idiopatickou hypersomnií. Cesk Slov Neurol N 2017; 80/113 (5): 561-563. doi: 10.14735/amcsnn2017561. Go to original source...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.